0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Different SWI/SNF complexes coordinately promote R-loop- and RAD52-dependent transcription-coupled homologous recombination

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The SWI/SNF family of ATP-dependent chromatin remodeling complexes is implicated in multiple DNA damage response mechanisms and frequently mutated in cancer. The BAF, PBAF and ncBAF complexes are three major types of SWI/SNF complexes that are functionally distinguished by their exclusive subunits. Accumulating evidence suggests that double-strand breaks (DSBs) in transcriptionally active DNA are preferentially repaired by a dedicated homologous recombination pathway. We show that different BAF, PBAF and ncBAF subunits promote homologous recombination and are rapidly recruited to DSBs in a transcription-dependent manner. The PBAF and ncBAF complexes promote RNA polymerase II eviction near DNA damage to rapidly initiate transcriptional silencing, while the BAF complex helps to maintain this transcriptional silencing. Furthermore, ARID1A-containing BAF complexes promote RNaseH1 and RAD52 recruitment to facilitate R-loop resolution and DNA repair. Our results highlight how multiple SWI/SNF complexes perform different functions to enable DNA repair in the context of actively transcribed genes.

          Graphical Abstract

          Graphical Abstract

          Related collections

          Most cited references83

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences

          The PRoteomics IDEntifications (PRIDE) database ( https://www.ebi.ac.uk/pride/ ) is the world's largest data repository of mass spectrometry-based proteomics data. PRIDE is one of the founding members of the global ProteomeXchange (PX) consortium and an ELIXIR core data resource. In this manuscript, we summarize the developments in PRIDE resources and related tools since the previous update manuscript was published in Nucleic Acids Research in 2019. The number of submitted datasets to PRIDE Archive (the archival component of PRIDE) has reached on average around 500 datasets per month during 2021. In addition to continuous improvements in PRIDE Archive data pipelines and infrastructure, the PRIDE Spectra Archive has been developed to provide direct access to the submitted mass spectra using Universal Spectrum Identifiers. As a key point, the file format MAGE-TAB for proteomics has been developed to enable the improvement of sample metadata annotation. Additionally, the resource PRIDE Peptidome provides access to aggregated peptide/protein evidences across PRIDE Archive. Furthermore, we will describe how PRIDE has increased its efforts to reuse and disseminate high-quality proteomics data into other added-value resources such as UniProt, Ensembl and Expression Atlas.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The DNA-damage response in human biology and disease.

            The prime objective for every life form is to deliver its genetic material, intact and unchanged, to the next generation. This must be achieved despite constant assaults by endogenous and environmental agents on the DNA. To counter this threat, life has evolved several systems to detect DNA damage, signal its presence and mediate its repair. Such responses, which have an impact on a wide range of cellular events, are biologically significant because they prevent diverse human diseases. Our improving understanding of DNA-damage responses is providing new avenues for disease management.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Repair Pathway Choices and Consequences at the Double-Strand Break.

              DNA double-strand breaks (DSBs) are cytotoxic lesions that threaten genomic integrity. Failure to repair a DSB has deleterious consequences, including genomic instability and cell death. Indeed, misrepair of DSBs can lead to inappropriate end-joining events, which commonly underlie oncogenic transformation due to chromosomal translocations. Typically, cells employ two main mechanisms to repair DSBs: homologous recombination (HR) and classical nonhomologous end joining (C-NHEJ). In addition, alternative error-prone DSB repair pathways, namely alternative end joining (alt-EJ) and single-strand annealing (SSA), have been recently shown to operate in many different conditions and to contribute to genome rearrangements and oncogenic transformation. Here, we review the mechanisms regulating DSB repair pathway choice, together with the potential interconnections between HR and the annealing-dependent error-prone DSB repair pathways.
                Bookmark

                Author and article information

                Contributors
                Journal
                Nucleic Acids Res
                Nucleic Acids Res
                nar
                Nucleic Acids Research
                Oxford University Press
                0305-1048
                1362-4962
                22 September 2023
                20 July 2023
                20 July 2023
                : 51
                : 17
                : 9055-9074
                Affiliations
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Erasmus Optical Imaging Center, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Proteomics Center, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam 3015 GD, The Netherlands
                Author notes
                To whom correspondence should be addressed. Tel: +31 10 7038027; Email: w.lans@ 123456erasmusmc.nl

                The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.

                Author information
                https://orcid.org/0000-0002-7182-6921
                https://orcid.org/0000-0001-5779-1681
                https://orcid.org/0000-0003-3616-734X
                https://orcid.org/0000-0003-4417-5358
                Article
                gkad609
                10.1093/nar/gkad609
                10516656
                37470997
                deca3eef-c61e-49f6-b690-27cf7adb547c
                © The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 10 July 2023
                : 05 July 2023
                : 09 November 2022
                Page count
                Pages: 20
                Funding
                Funded by: Netherlands Organization for Scientific Research;
                Award ID: ALWOP.494
                Funded by: Worldwide Cancer Research, DOI 10.13039/100011713;
                Award ID: 15-1274
                Funded by: Dutch Cancer Society KWF;
                Award ID: 10506
                Funded by: European Research Council, DOI 10.13039/501100000781;
                Award ID: 340988-ERC-ID
                Funded by: CancerGenomiCs.nl from Netherlands Organization for Scientific Research;
                Funded by: Oncode Institute, DOI 10.13039/501100021821;
                Funded by: Dutch Cancer Society;
                Categories
                AcademicSubjects/SCI00010
                Genome Integrity, Repair and Replication

                Genetics
                Genetics

                Comments

                Comment on this article